Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled Syringes), Drug Delivery, and Region - Global Forecast to 2028
The market for pharmaceutical packaging is approximated to be USD 132.0 billion in 2023, and it is projected to reach USD 269.9 billion by 2028 at a CAGR of 15.4%. The increasing demand for pharmaceutical packaging is driven by the surge in healthcare expenditures, necessitating a higher requirement for various packaging products such as strip packs, aerosol generators, collapsible tubes, canisters, implants, and blister packs. Technological advancements in the pharmaceutical packaging industry have given rise to innovative solutions such as smart packaging and sterile packaging, contributing to the overall growth of the market.
“By Type, Labels & accessories accounted for the third highest CAGR during the forecast period.”
The labels & accessories market is experiencing significant growth driven by the pharmaceutical packaging market. Labels & accessories in pharmaceutical packaging play a critical role in ensuring the safety, efficacy, and proper usage of medications. Labels play a crucial role in conveying vital information about a product, encompassing dosage instructions, expiration dates, and lists of ingredients. Additionally, labels aid in the identification and comprehension of the product, enhancing patient safety and ensuring compliance with regulatory standards. Accessories such as tamper-evident elements and child-resistant packaging are specifically crafted to safeguard products and deter unauthorized access, especially for medications carrying a risk if consumed by children or if the product's integrity is compromised.
“By Packaging Type, Primary packaging is the fastest growing packaging type during the forecast period.”
The primary packaging is the first and initial layer of packaging directly in contact with the drug and holds significant importance in preserving the quality and effectiveness of pharmaceutical products. This market encompasses diverse forms of packaging, including ampoules, vials, containers, strip packaging, blister packaging, syringes, bottles, and sachet packaging. The evolution of drug delivery systems frequently requires innovative primary packaging solutions to support novel administration methods, including prefilled inhalers, syringes, and other specialized devices. These factors drive the primary packaging segment in the pharmaceutical packaging market.
“By Drug Delivery, Injectables accounted for the second largest market during the forecast period.”
Injectable drug delivery modes are recognized as highly effective and successful routes of drug administration due to their rapid and efficient delivery to the target area. While most drugs are administered orally or through injections, injectables come in various forms such as self-injection devices, prefilled syringes, auto-injectors, safety syringes, patch injectors, pen injectors, and more. The growth of the biologics market is also anticipated to contribute to the expansion of the injectables market in the forecast period.
“By Raw Material, Paper & paperboard accounted for the second largest market share during the forecast period.”
Paperboard materials are widely used for secondary pharmaceutical packaging, such as cartons, blister wallets, and rigid boxes, due to their greater surface area and improved product display. The attributes of the paper substrate, such as surface properties, color, brightness, opacity, basis weight, grain direction, tensile strength, and tearing strength, are important considerations in the production of paperboard packaging. Anticipated future developments in paper and paperboard for pharmaceutical packaging, focusing on aspects such as branding, labeling, patient adherence functionality, braille compliance features, and the inclusion of regulatory information, are expected to contribute to market growth. There is a notable demand for visually appealing prints on paper-based packaging, further fostering the expansion of this segment.
“Europe is projected to account for the second largest market share in the pharmaceutical packaging market during the forecast period.”
In Europe, there is a growing demand for primary packaging products driven by advanced drug delivery modes such as prefilled inhalers and pre-filled syringes. Additionally, caps & closures, blister packs, and specialty bags contribute to the growing demand for primary packaging in the region. The rising demand for pharmaceutical packaging in the European region is driven by the growing activities in pharmaceutical research, production, and distribution. Significant advancements in the field of medical biopharmaceuticals are further boosting the market in the region. The pharmaceutical packaging industry has witnessed consistent growth in countries such as Germany, France, and the UK, owing to their health-conscious population.
Primaries-
By Company Type: Tier 1: 25%, Tier 2: 50%, and Tier 3: 25%
By Designation: C-level Executives: 30%, Directors: 20%, and Others: 50%
By Region: North America: 20%, Europe: 30%, Asia Pacific: 25%, Latin America: 15%, and Middle East & Africa: 10%
Companies Covered: Berry Global (US), Amcor Plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), and AptarGroup, Inc. (US) are some of the established players in the pharmaceutical packaging market.
Research Coverage
The market study covers the pharmaceutical packaging market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on type, packaging type, raw material, drug delivery, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the pharmaceutical packaging market.
Key Benefits of Buying the Report
The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall pharmaceutical packaging market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses and plan suitable go-to-market strategies.
The report provides insights on the following pointers:
“By Type, Labels & accessories accounted for the third highest CAGR during the forecast period.”
The labels & accessories market is experiencing significant growth driven by the pharmaceutical packaging market. Labels & accessories in pharmaceutical packaging play a critical role in ensuring the safety, efficacy, and proper usage of medications. Labels play a crucial role in conveying vital information about a product, encompassing dosage instructions, expiration dates, and lists of ingredients. Additionally, labels aid in the identification and comprehension of the product, enhancing patient safety and ensuring compliance with regulatory standards. Accessories such as tamper-evident elements and child-resistant packaging are specifically crafted to safeguard products and deter unauthorized access, especially for medications carrying a risk if consumed by children or if the product's integrity is compromised.
“By Packaging Type, Primary packaging is the fastest growing packaging type during the forecast period.”
The primary packaging is the first and initial layer of packaging directly in contact with the drug and holds significant importance in preserving the quality and effectiveness of pharmaceutical products. This market encompasses diverse forms of packaging, including ampoules, vials, containers, strip packaging, blister packaging, syringes, bottles, and sachet packaging. The evolution of drug delivery systems frequently requires innovative primary packaging solutions to support novel administration methods, including prefilled inhalers, syringes, and other specialized devices. These factors drive the primary packaging segment in the pharmaceutical packaging market.
“By Drug Delivery, Injectables accounted for the second largest market during the forecast period.”
Injectable drug delivery modes are recognized as highly effective and successful routes of drug administration due to their rapid and efficient delivery to the target area. While most drugs are administered orally or through injections, injectables come in various forms such as self-injection devices, prefilled syringes, auto-injectors, safety syringes, patch injectors, pen injectors, and more. The growth of the biologics market is also anticipated to contribute to the expansion of the injectables market in the forecast period.
“By Raw Material, Paper & paperboard accounted for the second largest market share during the forecast period.”
Paperboard materials are widely used for secondary pharmaceutical packaging, such as cartons, blister wallets, and rigid boxes, due to their greater surface area and improved product display. The attributes of the paper substrate, such as surface properties, color, brightness, opacity, basis weight, grain direction, tensile strength, and tearing strength, are important considerations in the production of paperboard packaging. Anticipated future developments in paper and paperboard for pharmaceutical packaging, focusing on aspects such as branding, labeling, patient adherence functionality, braille compliance features, and the inclusion of regulatory information, are expected to contribute to market growth. There is a notable demand for visually appealing prints on paper-based packaging, further fostering the expansion of this segment.
“Europe is projected to account for the second largest market share in the pharmaceutical packaging market during the forecast period.”
In Europe, there is a growing demand for primary packaging products driven by advanced drug delivery modes such as prefilled inhalers and pre-filled syringes. Additionally, caps & closures, blister packs, and specialty bags contribute to the growing demand for primary packaging in the region. The rising demand for pharmaceutical packaging in the European region is driven by the growing activities in pharmaceutical research, production, and distribution. Significant advancements in the field of medical biopharmaceuticals are further boosting the market in the region. The pharmaceutical packaging industry has witnessed consistent growth in countries such as Germany, France, and the UK, owing to their health-conscious population.
Primaries-
By Company Type: Tier 1: 25%, Tier 2: 50%, and Tier 3: 25%
By Designation: C-level Executives: 30%, Directors: 20%, and Others: 50%
By Region: North America: 20%, Europe: 30%, Asia Pacific: 25%, Latin America: 15%, and Middle East & Africa: 10%
Companies Covered: Berry Global (US), Amcor Plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), and AptarGroup, Inc. (US) are some of the established players in the pharmaceutical packaging market.
Research Coverage
The market study covers the pharmaceutical packaging market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on type, packaging type, raw material, drug delivery, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the pharmaceutical packaging market.
Key Benefits of Buying the Report
The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall pharmaceutical packaging market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses and plan suitable go-to-market strategies.
The report provides insights on the following pointers:
- Analysis of drivers (the rising demand for pharmaceutical packaging in the pharmaceutical industry), restraints (raw material cost of pharmaceutical packaging products), opportunities (growing demand for sustainable packaging), and challenges (safeguarding against counterfeit products in pharmaceutical packaging) influencing the growth of pharmaceutical packaging market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and mergers & acquisitions in the pharmaceutical packaging market.
- Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for pharmaceutical packaging market across regions.
- Market Diversification: Exhaustive information about new products % services, untapped geographies, recent developments, and investments in the pharmaceutical packaging market
- Market Penetration: Comprehensive information on the pharmaceutical packaging market offered by top players in the global market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the pharmaceutical packaging
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
TABLE 1 PHARMACEUTICAL PACKAGING MARKET: INCLUSIONS & EXCLUSIONS
1.4 STUDY SCOPE
FIGURE 1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION
1.4.1 REGIONS COVERED
FIGURE 2 REGIONAL SCOPE
1.4.2 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 UNITS CONSIDERED
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key secondary sources
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 4 PHARMACEUTICAL PACKAGING MARKET: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 5 PHARMACEUTICAL PACKAGING MARKET: TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
FIGURE 6 PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION
2.3.1 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH PRIMARY SOURCES
2.3.2 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH SECONDARY SOURCES
FIGURE 7 PHARMACEUTICAL PACKAGING MARKET ANALYSIS
2.4 RESEARCH ASSUMPTIONS
2.5 FACTOR ANALYSIS
2.6 GROWTH ESTIMATION
2.6.1 SUPPLY SIDE
2.6.2 DEMAND SIDE
2.7 LIMITATIONS & RISKS
2.8 RECESSION IMPACT
3 EXECUTIVE SUMMARY
FIGURE 8 PLASTIC BOTTLES TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
FIGURE 9 PLASTICS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
FIGURE 10 ORAL DRUG DELIVERY MODE TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 11 PRIMARY PACKAGING TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD
FIGURE 12 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL PACKAGING MARKET
FIGURE 13 ASIA PACIFIC TO OFFER LUCRATIVE OPPORTUNITIES IN PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD
4.2 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
FIGURE 14 PREFILLED SYRINGES TO RECORD FASTEST GROWTH DURING
FORECAST PERIOD
4.3 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
FIGURE 15 PLASTICS SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD
4.4 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY
FIGURE 16 INJECTABLES SEGMENT TO BE FASTEST-GROWING MARKET BY 2028
4.5 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE
FIGURE 17 PRIMARY SEGMENT TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
4.6 PHARMACEUTICAL PACKAGING MARKET, BY KEY COUNTRY
FIGURE 18 INDIA TO DOMINATE MARKET DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET
5.2.1 DRIVERS
5.2.1.1 Surge in healthcare expenditure and growth of pharmaceutical industry
5.2.1.2 Rising demand for drug delivery devices and blister packaging
5.2.1.3 Technological advancements in pharmaceutical packaging
5.2.1.3.1 Nanomedicine and nano drug delivery systems
5.2.1.3.2 Child-resistant packaging
5.2.1.3.3 Radio-frequency identification
5.2.1.3.4 Micro-pump technology
5.2.1.3.5 Eco-friendly and sustainable packaging
5.2.2 RESTRAINTS
5.2.2.1 Surge in packaging costs due to dynamic regulatory policies
5.2.2.2 Restricted access to healthcare systems in emerging economies
5.2.3 OPPORTUNITIES
5.2.3.1 Growing demand for primary pharmaceutical packaging
5.2.4 CHALLENGES
5.2.4.1 Safeguarding against counterfeit products
5.3 VALUE CHAIN ANALYSIS
FIGURE 20 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS
5.3.1 RAW MATERIAL SUPPLIERS
5.3.2 R&D OF PRODUCTS
5.3.3 MANUFACTURERS
5.3.4 DISTRIBUTORS
5.3.5 END USERS
5.4 PORTER’S FIVE FORCES ANALYSIS
FIGURE 21 PORTER’S FIVE FORCES ANALYSIS OF PHARMACEUTICAL PACKAGING MARKET
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF BUYERS
5.4.4 BARGAINING POWER OF SUPPLIERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
TABLE 2 IMPACT OF PORTER’S FIVE FORCES ON PHARMACEUTICAL PACKAGING MARKET
5.5 MACROECONOMIC INDICATORS
5.5.1 GLOBAL GDP TRENDS
TABLE 3 TRENDS OF PER CAPITA GDP (USD), 2019–2021
TABLE 4 GDP GROWTH ESTIMATE AND PROJECTION OF KEY COUNTRIES, 2022–2027
TABLE 5 CURRENT HEALTH EXPENDITURE (% OF GDP) OF KEY COUNTRIES, 2018–2020
5.6 TARIFF & REGULATORY LANDSCAPE
5.6.1 REGULATIONS
5.6.1.1 Europe
5.6.1.2 US
5.6.1.3 Others
5.6.2 STANDARDS
5.6.2.1 ISO 9001
5.6.2.2 ISO 22000
5.6.2.3 ASTM D3475
5.6.2.4 USP (United States Pharmacopeia) Standards
5.6.2.5 Child-resistant Packaging Standards
5.6.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 TECHNOLOGY ANALYSIS
5.7.1 NANOTECHNOLOGY
5.7.2 PACKAGING FOR BIOLOGICS
5.7.3 SMART PACKAGING
5.7.4 ANTI-COUNTERFEIT PACKAGING
5.7.5 OTHER SMART TRENDS AND TECHNOLOGIES
5.8 PRICING ANALYSIS
5.8.1 AVERAGE SELLING PRICE, BY REGION
FIGURE 22 AVERAGE SELLING PRICE, BY REGION (USD/KG)
5.8.2 AVERAGE SELLING PRICE, BY RAW MATERIAL
TABLE 7 AVERAGE SELLING PRICE, BY RAW MATERIAL (USD/KG)
5.9 ECOSYSTEM/MARKET MAP
FIGURE 23 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING
TABLE 8 PHARMACEUTICAL PACKAGING MARKET: ROLE IN ECOSYSTEM
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 24 SUSTAINABLE PACKAGING, IOT, AND NANOTECHNOLOGY TO DRIVE FUTURE GROWTH
5.11 PATENT ANALYSIS
5.11.1 INTRODUCTION
5.11.2 METHODOLOGY
5.11.3 DOCUMENT TYPES
FIGURE 25 PATENTS REGISTERED (2012–2022)
5.11.4 PUBLICATION TRENDS
FIGURE 26 NUMBER OF PATENTS IN LAST 10 YEARS, 2012–2022
5.11.5 INSIGHTS
5.11.6 JURISDICTION ANALYSIS
FIGURE 27 TOP JURISDICTIONS
5.11.7 TOP APPLICANTS
FIGURE 28 TOP 10 PATENT APPLICANTS
TABLE 9 PATENTS BY SANOFI
TABLE 10 PATENTS BY SCHOTT AG
TABLE 11 PATENTS BY NOVARTIS AG
FIGURE 29 TOP 10 PATENT OWNERS
TABLE 12 TOP 10 PATENT OWNERS IN LAST 10 YEARS
5.12 RAW MATERIAL ANALYSIS
5.12.1 PLASTICS
5.12.2 PAPER
5.12.3 GLASS
5.12.4 METALS
5.13 TRADE ANALYSIS
5.13.1 IMPORT SCENARIO
TABLE 13 REGION-WISE IMPORT TRADE (USD MILLION)
FIGURE 30 REGION-WISE IMPORT TRADE (USD MILLION)
5.13.2 EXPORT SCENARIO
TABLE 14 REGION-WISE EXPORT TRADE (USD MILLION)
FIGURE 31 REGION-WISE EXPORT TRADE (USD MILLION)
5.14 KEY CONFERENCES & EVENTS IN 2024–2025
TABLE 15 KEY CONFERENCES & EVENTS IN 2023–2024
5.15 CASE STUDY ANALYSIS
5.15.1 MOISTURE BARRIER TECHNOLOGY FOR EFFICIENT DRUG DELIVERY
5.15.2 CUSTOM METERING VALVE FOR INHALERS
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE DRUG DELIVERY MODES
5.16.2 BUYING CRITERIA
5.16.2.1 Quality
5.16.2.2 Service
FIGURE 32 SUPPLIER SELECTION CRITERION
6 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE
6.1 INTRODUCTION
FIGURE 33 PRIMARY PACKAGING TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD
TABLE 17 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
TABLE 18 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
6.2 PRIMARY
6.2.1 INNOVATIVE PACKAGING SOLUTIONS FOR DRUG DELIVERY SYSTEMS TO DRIVE MARKET
6.3 SECONDARY
6.3.1 RISING ADOPTION OF PREFILLED CONTAINERS AND DELIVERY DEVICES TO FUEL DEMAND
7 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
7.1 INTRODUCTION
FIGURE 34 PLASTICS TO DOMINATE MARKET DURING FORECAST PERIOD
TABLE 19 BASIC PACKAGING RAW MATERIALS USED IN PHARMACEUTICAL PACKAGING
TABLE 20 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
TABLE 21 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
TABLE 22 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
TABLE 23 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
7.2 PLASTIC
7.2.1 EFFECTIVE BARRIER PROPERTIES AND COST REDUCTION TO DRIVE MARKET
TABLE 24 PLASTICS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 25 PLASTICS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
7.2.2 HIGH-DENSITY POLYETHYLENE
7.2.3 POLYESTER
7.2.4 POLYPROPYLENE
7.2.5 LOW-DENSITY POLYETHYLENE
7.2.6 POLYVINYL CHLORIDE
7.2.7 CYCLIC OLEFIN COPOLYMER
7.2.8 POLYETHYLENE TEREPHTHALATE
7.3 PAPER & PAPERBOARD
7.3.1 INNOVATIONS IN SECONDARY PACKAGING TO PROPEL MARKET
TABLE 26 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 27 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
7.4 GLASS
7.4.1 CHEMICAL RESISTANCE AND STURDINESS TO BOOST DEMAND
TABLE 28 GLASS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 29 GLASS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
TABLE 30 GLASS PACKAGING TYPES
7.5 METALS
7.5.1 INCREASING USE OF ALUMINUM FOR BLISTER PACKAGING TO DRIVE MARKET
TABLE 31 METALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 32 METALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
7.6 OTHER RAW MATERIALS
TABLE 33 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 34 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY
8.1 INTRODUCTION
FIGURE 35 ORAL DRUG DELIVERY ACCOUNTED FOR LARGEST SHARE IN 2023
TABLE 35 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 36 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
TABLE 37 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
TABLE 38 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
8.2 ORAL
8.2.1 ADOPTION OF NANOCARRIERS AND CYCLODEXTRINS TO FUEL MARKET
TABLE 39 ORAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 40 ORAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.3 PULMONARY
8.3.1 INCREASING CASES OF LUNG DISORDERS TO DRIVE MARKET
TABLE 41 PULMONARY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 42 PULMONARY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.4 TRANSDERMAL
8.4.1 SURGING DEMAND FOR PAINLESS DRUG DELIVERY AND SELF-ADMINISTRATION OF DRUGS TO FUEL MARKET
TABLE 43 TRANSDERMAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 44 TRANSDERMAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.5 INJECTABLE
8.5.1 INCREASING USE OF BIOLOGICS TO BOOST MARKET
TABLE 45 INJECTABLE: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 46 INJECTABLE: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.6 TOPICAL
8.6.1 RISING PREVALENCE OF SKIN DISEASES TO BOOST DEMAND FOR TOPICAL DRUGS
TABLE 47 TOPICAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 48 TOPICAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.7 NASAL
8.7.1 RAPID ABSORPTION AND QUICK ACTION TO FUEL DEMAND FOR NASAL DROPS
TABLE 49 NASAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 50 NASAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.8 OCULAR/OPHTHALMIC
8.8.1 INCREASING FREQUENCY OF OPTHALMIC DISEASES TO DRIVE MARKET
TABLE 51 OCULAR/OPHTHALMIC: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 52 OCULAR/OPHTHALMIC: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.9 INTRAVENOUS
8.9.1 HIGH OCCURENCE OF CHRONIC DISEASES TO FUEL MARKET
TABLE 53 INTRAVENOUS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 54 INTRAVENOUS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.10 OTHER DRUG DELIVERY MODES
TABLE 55 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 56 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
9.1 INTRODUCTION
FIGURE 36 PLASTIC BOTTLES TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
TABLE 57 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 58 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
9.2 PLASTIC BOTTLES
9.2.1 EXTENSIVE USE IN PACKAGING ORAL DRUGS TO BOOST MARKET
TABLE 59 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 60 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.2.2 STANDARD PLASTIC BOTTLES
9.2.3 PLASTIC DISPENSING BOTTLES
9.2.4 PLASTIC JARS
9.3 BLISTER PACKS
9.3.1 ANTIMICROBIAL RESISTANCE AND TAMPER-EVIDENT FEATURES TO DRIVE MARKET
TABLE 61 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 62 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.3.2 COMPARTMENT PACKS
9.3.3 WALLET PACKS
9.4 LABELS & ACCESSORIES
9.4.1 NEED FOR STRINGENT GUIDELINES ON DRUG INSTRUCTIONS TO FUEL DEMAND
TABLE 63 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 64 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.4.2 SELF ADHESIVE
9.4.3 DIE CUT
9.4.4 HOLOGRAPHIC STRIPS
9.4.5 TAMPER PROOF
9.4.6 OTHER LABELS
9.5 CAPS & CLOSURES
9.5.1 DEMAND FOR CHILD-RESISTANT AND TAMPER-EVIDENT PACKAGING TO FUEL MARKET
TABLE 65 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 66 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.6 MEDICAL SPECIALTY BAGS
9.6.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND
TABLE 67 MEDICAL SPECIALTY BAGS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 68 MEDICAL SPECIALTY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.7 PREFILLED SYRINGES
9.7.1 RISING NEED FOR HIGH-QUALITY DRUG DELIVERY SYSTEMS TO BOOST MARKET
TABLE 69 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 70 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.8 TEMPERATURE-CONTROLLED PACKAGING
9.8.1 SURGING DEMAND FOR TEMPERATURE-SENSITIVE DRUGS AND VACCINES TO FUEL MARKET
TABLE 71 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 72 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.9 POUCHES & STRIP PACKS
9.9.1 INCREASING DEMAND FOR COST-EFFECTIVE SOLUTIONS TO DRIVE MARKET
TABLE 73 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 74 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.10 AMPOULES
9.10.1 HIGH REQUIREMENT FOR SMALL DOSAGE SOLUTIONS TO DRIVE MARKET
TABLE 75 AMPOULES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 76 AMPOULES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.11 VIALS
9.11.1 CONSISTENT DEMAND FOR VIALS IN VACCINE PACKAGING TO DRIVE MARKET
TABLE 77 VIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 78 VIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.12 PREFILLED INHALERS
9.12.1 HIGH DEMAND FOR CONVENIENT AND ECO-FRIENDLY PACKAGING TO DRIVE MARKET
TABLE 79 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 80 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.12.2 METERED DOSE INHALERS
9.12.3 DRY POWDER INHALERS
9.13 MEDICATION TUBES
9.13.1 INCREASING DEMAND IN CURING SKIN AILMENTS TO DRIVE MARKET
TABLE 81 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 82 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.13.2 COMPOSITE TUBES
9.13.3 ALL-PLASTIC TUBES
9.13.4 COLLAPSIBLE METAL TUBES
9.14 JARS & CANISTERS
9.14.1 EFFECTIVE BARRIER PROPERTIES TO FUEL DEMAND FOR DESICCANT CANISTERS
TABLE 83 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 84 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.15 CARTRIDGES
9.15.1 INCREASED USE IN CHRONIC DISEASES TO DRIVE MARKET
TABLE 85 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 86 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.16 OTHER TYPES
TABLE 87 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 88 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
10 PHARMACEUTICAL PACKAGING MARKET, BY REGION
10.1 INTRODUCTION
FIGURE 37 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
TABLE 89 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 90 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
10.2 NORTH AMERICA
10.2.1 RECESSION IMPACT
FIGURE 38 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
TABLE 91 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
TABLE 92 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 93 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 94 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
TABLE 95 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
TABLE 96 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
TABLE 97 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
TABLE 98 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
TABLE 99 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
TABLE 100 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
TABLE 101 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
TABLE 102 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
10.2.2 US
10.2.2.1 Rapid technological advancements in pharmaceutical packaging to drive market
TABLE 103 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 104 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Competitive business environment to boost market
TABLE 105 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 106 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.2.4 MEXICO
10.2.4.1 Government initiatives in healthcare industry to fuel demand for pharmaceutical products
TABLE 107 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 108 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3 EUROPE
10.3.1 RECESSION IMPACT
FIGURE 39 EUROPE: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
TABLE 109 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
TABLE 110 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 111 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 112 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
TABLE 113 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
TABLE 114 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
TABLE 115 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
TABLE 116 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
TABLE 117 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
TABLE 118 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
TABLE 119 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
TABLE 120 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
10.3.2 GERMANY
10.3.2.1 Increase in aging population and noncommunicable diseases to drive market
TABLE 121 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 122 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 High demand for generic drugs to drive market
TABLE 123 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 124 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Rising exports of pharmaceutical products to boost market
TABLE 125 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 126 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.5 UK
10.3.5.1 Innovations in drug manufacturing to drive market
TABLE 127 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 128 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Government initiatives in healthcare sector to boost demand
TABLE 129 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 130 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.7 RUSSIA
10.3.7.1 Government initiatives for domestic production of pharmaceuticals to fuel market
TABLE 131 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 132 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.8 REST OF EUROPE
TABLE 133 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 134 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4 ASIA PACIFIC
10.4.1 RECESSION IMPACT
FIGURE 40 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
TABLE 135 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
TABLE 136 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 137 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 138 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
TABLE 139 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
TABLE 140 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
TABLE 141 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
TABLE 142 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
TABLE 143 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
TABLE 144 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
TABLE 145 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
TABLE 146 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
10.4.2 CHINA
10.4.2.1 Increased investments in biologics and biosimilar drug research to drive market
TABLE 147 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 148 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4.3 JAPAN
10.4.3.1 Rise in aging population to drive demand for medications
TABLE 149 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 150 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4.4 SOUTH KOREA
10.4.4.1 Well-developed healthcare industry and presence of major pharmaceuticals manufacturers to drive market
TABLE 151 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 152 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4.5 INDIA
10.4.5.1 Large domestic consumption and export of generic drugs to drive market
TABLE 153 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 154 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4.6 AUSTRALIA
10.4.6.1 Wide adoption of Medicare and PBS schemes to drive market
TABLE 155 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 156 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4.7 REST OF ASIA PACIFIC
TABLE 157 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 158 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.5 SOUTH AMERICA
10.5.1 RECESSION IMPACT
TABLE 159 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
TABLE 160 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 161 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 162 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
TABLE 163 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
TABLE 164 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
TABLE 165 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
TABLE 166 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
TABLE 167 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
TABLE 168 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
TABLE 169 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
TABLE 170 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
10.5.2 BRAZIL
10.5.2.1 Free and universal healthcare services to boost market
TABLE 171 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 172 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.5.3 ARGENTINA
10.5.3.1 Rapid urbanization and increase in import of drugs to fuel market
TABLE 173 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 174 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.5.4 REST OF SOUTH AMERICA
TABLE 175 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 176 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 RECESSION IMPACT
TABLE 177 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
TABLE 178 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
TABLE 181 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
TABLE 182 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
TABLE 183 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
TABLE 184 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
TABLE 185 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
TABLE 186 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
TABLE 187 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
TABLE 188 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
10.6.2 GCC
10.6.2.1 UAE
10.6.2.1.1 Increasing initiatives for domestic pharmaceutical production to drive market
TABLE 189 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 190 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.6.2.2 Saudi Arabia
10.6.2.2.1 More comprehensive access to healthcare services to fuel demand for pharmaceuticals
TABLE 191 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 192 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.6.2.3 Rest of GCC
10.6.3 SOUTH AFRICA
10.6.3.1 Gradual rise in use of generic drugs to drive market
TABLE 193 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 194 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.6.4 REST OF MIDDLE EAST & AFRICA
TABLE 195 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 196 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
FIGURE 41 OVERVIEW OF KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS BETWEEN 2019 AND 2023
11.3 REVENUE ANALYSIS
FIGURE 42 REVENUE ANALYSIS OF KEY COMPANIES (2020–2022)
11.4 MARKET SHARE ANALYSIS
11.4.1 RANKING ANALYSIS OF KEY MARKET PLAYERS, 2022
FIGURE 43 RANKING OF TOP 5 PLAYERS IN PHARMACEUTICAL PACKAGING MARKET, 2022
11.4.2 MARKET SHARE OF KEY PLAYERS, 2022
FIGURE 44 PHARMACEUTICAL PACKAGING MARKET SHARE, BY COMPANY (2022)
TABLE 197 PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 45 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX, 2022
11.5.5 COMPANY FOOTPRINT
TABLE 198 PACKAGING TYPE FOOTPRINT (25 COMPANIES)
TABLE 199 DRUG DELIVERY MODE FOOTPRINT (25 COMPANIES)
TABLE 200 REGION FOOTPRINT (25 COMPANIES)
TABLE 201 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
11.6 START-UP/SME EVALUATION MATRIX
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
FIGURE 46 PHARMACEUTICAL PACKAGING MARKET: START-UP/SME EVALUATION MATRIX, 2022
11.6.5 COMPETITIVE BENCHMARKING
TABLE 202 PHARMACEUTICAL PACKAGING MARKET: LIST OF COMPANIES (25 COMPANIES)
11.7 COMPETITIVE SCENARIO AND TRENDS
11.7.1 PRODUCT LAUNCHES/DEVELOPMENTS
TABLE 203 PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES/ DEVELOPMENTS, 2019–2023
11.7.2 DEALS
TABLE 204 PHARMACEUTICAL PACKAGING MARKET: DEALS, 2019–2023
11.7.3 OTHER DEVELOPMENTS
TABLE 205 PHARMACEUTICAL PACKAGING MARKET: OTHER DEVELOPMENTS,
2019–2023
12 COMPANY PROFILES
(Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats) *
12.1 KEY PLAYERS
12.1.1 BERRY GLOBAL INC.
TABLE 206 BERRY GLOBAL INC.: COMPANY OVERVIEW
FIGURE 47 BERRY GLOBAL INC.: COMPANY SNAPSHOT
TABLE 207 BERRY GLOBAL INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 208 BERRY GLOBAL INC.: PRODUCT LAUNCHES
TABLE 209 BERRY GLOBAL INC.: DEALS
TABLE 210 BERRY GLOBAL INC.: OTHER DEVELOPMENTS
12.1.2 GERRESHEIMER AG
TABLE 211 GERRESHEIMER AG: COMPANY OVERVIEW
FIGURE 48 GERRESHEIMER AG: COMPANY SNAPSHOT
TABLE 212 GERRESHEIMER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 213 GERRESHEIMER AG: PRODUCT LAUNCHES
TABLE 214 GERRESHEIMER AG: DEALS
TABLE 215 GERRESHEIMER AG: OTHER DEVELOPMENTS
12.1.3 AMCOR PLC
TABLE 216 AMCOR PLC: COMPANY OVERVIEW
FIGURE 49 AMCOR PLC: COMPANY SNAPSHOT
TABLE 217 AMCOR PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 218 AMCOR PLC: PRODUCT LAUNCHES
TABLE 219 AMCOR PLC: DEALS
TABLE 220 AMCOR PLC: OTHER DEVELOPMENTS
12.1.4 SCHOTT AG
TABLE 221 SCHOTT AG: COMPANY OVERVIEW
FIGURE 50 SCHOTT AG: COMPANY SNAPSHOT
TABLE 222 SCHOTT AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 223 SCHOTT AG: PRODUCT LAUNCHES
TABLE 224 SCHOTT AG: DEALS
TABLE 225 SCHOTT AG: OTHER DEVELOPMENTS
12.1.5 APTARGROUP, INC.
TABLE 226 APTARGROUP, INC.: COMPANY OVERVIEW
FIGURE 51 APTARGROUP, INC.: COMPANY SNAPSHOT
TABLE 227 APTARGROUP, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 228 APTARGROUP, INC.: PRODUCT LAUNCHES
TABLE 229 APTARGROUP, INC.: DEALS
TABLE 230 APTARGROUP, INC.: OTHER DEVELOPMENTS
12.1.6 BD
TABLE 231 BD: COMPANY OVERVIEW
FIGURE 52 BD: COMPANY SNAPSHOT
TABLE 232 BD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 233 BD: PRODUCT LAUNCHES
TABLE 234 BD: DEALS
TABLE 235 BD: OTHER DEVELOPMENTS
12.1.7 WESTROCK COMPANY
TABLE 236 WESTROCK COMPANY: COMPANY OVERVIEW
FIGURE 53 WESTROCK COMPANY: COMPANY SNAPSHOT
TABLE 237 WESTROCK COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 238 WESTROCK COMPANY: DEALS
TABLE 239 WESTROCK COMPANY: OTHER DEVELOPMENTS
12.1.8 NIPRO CORPORATION
TABLE 240 NIPRO CORPORATION: COMPANY OVERVIEW
FIGURE 54 NIPRO CORPORATION: COMPANY SNAPSHOT
TABLE 241 NIPRO CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 242 NIPRO CORPORATION: PRODUCT LAUNCHES
TABLE 243 NIPRO CORPORATION: DEALS
12.1.9 CATALENT, INC.
TABLE 244 CATALENT, INC.: COMPANY OVERVIEW
FIGURE 55 CATALENT, INC.: COMPANY SNAPSHOT
TABLE 245 CATALENT, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 246 CATALENT, INC.: DEALS
TABLE 247 CATALENT, INC.: OTHER DEVELOPMENTS
12.1.10 SEALED AIR
TABLE 248 SEALED AIR: COMPANY OVERVIEW
FIGURE 56 SEALED AIR: COMPANY SNAPSHOT
TABLE 249 SEALED AIR: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 250 SEALED AIR: PRODUCT LAUNCHES
TABLE 251 SEALED AIR: DEALS
12.1.11 WEST PHARMACEUTICAL SERVICES, INC.
TABLE 252 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW
FIGURE 57 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT
TABLE 253 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 254 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT LAUNCHES
TABLE 255 WEST PHARMACEUTICAL SERVICES, INC.: OTHER DEVELOPMENTS
*Details on Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS
12.2.1 ALPLA
TABLE 256 ALPLA: COMPANY OVERVIEW
12.2.2 ARDAGH GROUP S.A.
TABLE 257 ARDAGH GROUP S.A.: COMPANY OVERVIEW
12.2.3 CCL INDUSTRIES INC.
TABLE 258 CCL INDUSTRIES INC.: COMPANY OVERVIEW
12.2.4 FRANK NOE
TABLE 259 FRANK NOE: COMPANY OVERVIEW
12.2.5 GAPLAST GMBH
TABLE 260 GAPLAST GMBH: COMPANY OVERVIEW
12.2.6 LONZA
TABLE 261 LONZA: COMPANY OVERVIEW
12.2.7 MONDI GROUP
TABLE 262 MONDI GROUP: COMPANY OVERVIEW
12.2.8 NOLATO AB
TABLE 263 NOLATO AB: COMPANY OVERVIEW
12.2.9 ORIGIN PHARMA PACKAGING
TABLE 264 ORIGIN PHARMA PACKAGING: COMPANY OVERVIEW
12.2.10 COMAR
TABLE 265 COMAR: COMPANY OVERVIEW
12.2.11 BILCARE LIMITED
TABLE 266 BILCARE LIMITED: COMPANY OVERVIEW
12.2.12 SGD PHARMA
TABLE 267 SGD PHARMA: COMPANY OVERVIEW
12.2.13 SILGAN HOLDINGS INC.
TABLE 268 SILGAN HOLDINGS INC.: COMPANY OVERVIEW
12.2.14 VETTER PHARMA INTERNATIONAL GMBH
TABLE 269 VETTER PHARMA INTERNATIONAL GMBH: COMPANY OVERVIEW
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
TABLE 1 PHARMACEUTICAL PACKAGING MARKET: INCLUSIONS & EXCLUSIONS
1.4 STUDY SCOPE
FIGURE 1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION
1.4.1 REGIONS COVERED
FIGURE 2 REGIONAL SCOPE
1.4.2 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 UNITS CONSIDERED
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key secondary sources
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 4 PHARMACEUTICAL PACKAGING MARKET: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 5 PHARMACEUTICAL PACKAGING MARKET: TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
FIGURE 6 PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION
2.3.1 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH PRIMARY SOURCES
2.3.2 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH SECONDARY SOURCES
FIGURE 7 PHARMACEUTICAL PACKAGING MARKET ANALYSIS
2.4 RESEARCH ASSUMPTIONS
2.5 FACTOR ANALYSIS
2.6 GROWTH ESTIMATION
2.6.1 SUPPLY SIDE
2.6.2 DEMAND SIDE
2.7 LIMITATIONS & RISKS
2.8 RECESSION IMPACT
3 EXECUTIVE SUMMARY
FIGURE 8 PLASTIC BOTTLES TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
FIGURE 9 PLASTICS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
FIGURE 10 ORAL DRUG DELIVERY MODE TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 11 PRIMARY PACKAGING TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD
FIGURE 12 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL PACKAGING MARKET
FIGURE 13 ASIA PACIFIC TO OFFER LUCRATIVE OPPORTUNITIES IN PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD
4.2 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
FIGURE 14 PREFILLED SYRINGES TO RECORD FASTEST GROWTH DURING
FORECAST PERIOD
4.3 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
FIGURE 15 PLASTICS SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD
4.4 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY
FIGURE 16 INJECTABLES SEGMENT TO BE FASTEST-GROWING MARKET BY 2028
4.5 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE
FIGURE 17 PRIMARY SEGMENT TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
4.6 PHARMACEUTICAL PACKAGING MARKET, BY KEY COUNTRY
FIGURE 18 INDIA TO DOMINATE MARKET DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET
5.2.1 DRIVERS
5.2.1.1 Surge in healthcare expenditure and growth of pharmaceutical industry
5.2.1.2 Rising demand for drug delivery devices and blister packaging
5.2.1.3 Technological advancements in pharmaceutical packaging
5.2.1.3.1 Nanomedicine and nano drug delivery systems
5.2.1.3.2 Child-resistant packaging
5.2.1.3.3 Radio-frequency identification
5.2.1.3.4 Micro-pump technology
5.2.1.3.5 Eco-friendly and sustainable packaging
5.2.2 RESTRAINTS
5.2.2.1 Surge in packaging costs due to dynamic regulatory policies
5.2.2.2 Restricted access to healthcare systems in emerging economies
5.2.3 OPPORTUNITIES
5.2.3.1 Growing demand for primary pharmaceutical packaging
5.2.4 CHALLENGES
5.2.4.1 Safeguarding against counterfeit products
5.3 VALUE CHAIN ANALYSIS
FIGURE 20 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS
5.3.1 RAW MATERIAL SUPPLIERS
5.3.2 R&D OF PRODUCTS
5.3.3 MANUFACTURERS
5.3.4 DISTRIBUTORS
5.3.5 END USERS
5.4 PORTER’S FIVE FORCES ANALYSIS
FIGURE 21 PORTER’S FIVE FORCES ANALYSIS OF PHARMACEUTICAL PACKAGING MARKET
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF BUYERS
5.4.4 BARGAINING POWER OF SUPPLIERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
TABLE 2 IMPACT OF PORTER’S FIVE FORCES ON PHARMACEUTICAL PACKAGING MARKET
5.5 MACROECONOMIC INDICATORS
5.5.1 GLOBAL GDP TRENDS
TABLE 3 TRENDS OF PER CAPITA GDP (USD), 2019–2021
TABLE 4 GDP GROWTH ESTIMATE AND PROJECTION OF KEY COUNTRIES, 2022–2027
TABLE 5 CURRENT HEALTH EXPENDITURE (% OF GDP) OF KEY COUNTRIES, 2018–2020
5.6 TARIFF & REGULATORY LANDSCAPE
5.6.1 REGULATIONS
5.6.1.1 Europe
5.6.1.2 US
5.6.1.3 Others
5.6.2 STANDARDS
5.6.2.1 ISO 9001
5.6.2.2 ISO 22000
5.6.2.3 ASTM D3475
5.6.2.4 USP (United States Pharmacopeia) Standards
5.6.2.5 Child-resistant Packaging Standards
5.6.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 TECHNOLOGY ANALYSIS
5.7.1 NANOTECHNOLOGY
5.7.2 PACKAGING FOR BIOLOGICS
5.7.3 SMART PACKAGING
5.7.4 ANTI-COUNTERFEIT PACKAGING
5.7.5 OTHER SMART TRENDS AND TECHNOLOGIES
5.8 PRICING ANALYSIS
5.8.1 AVERAGE SELLING PRICE, BY REGION
FIGURE 22 AVERAGE SELLING PRICE, BY REGION (USD/KG)
5.8.2 AVERAGE SELLING PRICE, BY RAW MATERIAL
TABLE 7 AVERAGE SELLING PRICE, BY RAW MATERIAL (USD/KG)
5.9 ECOSYSTEM/MARKET MAP
FIGURE 23 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING
TABLE 8 PHARMACEUTICAL PACKAGING MARKET: ROLE IN ECOSYSTEM
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 24 SUSTAINABLE PACKAGING, IOT, AND NANOTECHNOLOGY TO DRIVE FUTURE GROWTH
5.11 PATENT ANALYSIS
5.11.1 INTRODUCTION
5.11.2 METHODOLOGY
5.11.3 DOCUMENT TYPES
FIGURE 25 PATENTS REGISTERED (2012–2022)
5.11.4 PUBLICATION TRENDS
FIGURE 26 NUMBER OF PATENTS IN LAST 10 YEARS, 2012–2022
5.11.5 INSIGHTS
5.11.6 JURISDICTION ANALYSIS
FIGURE 27 TOP JURISDICTIONS
5.11.7 TOP APPLICANTS
FIGURE 28 TOP 10 PATENT APPLICANTS
TABLE 9 PATENTS BY SANOFI
TABLE 10 PATENTS BY SCHOTT AG
TABLE 11 PATENTS BY NOVARTIS AG
FIGURE 29 TOP 10 PATENT OWNERS
TABLE 12 TOP 10 PATENT OWNERS IN LAST 10 YEARS
5.12 RAW MATERIAL ANALYSIS
5.12.1 PLASTICS
5.12.2 PAPER
5.12.3 GLASS
5.12.4 METALS
5.13 TRADE ANALYSIS
5.13.1 IMPORT SCENARIO
TABLE 13 REGION-WISE IMPORT TRADE (USD MILLION)
FIGURE 30 REGION-WISE IMPORT TRADE (USD MILLION)
5.13.2 EXPORT SCENARIO
TABLE 14 REGION-WISE EXPORT TRADE (USD MILLION)
FIGURE 31 REGION-WISE EXPORT TRADE (USD MILLION)
5.14 KEY CONFERENCES & EVENTS IN 2024–2025
TABLE 15 KEY CONFERENCES & EVENTS IN 2023–2024
5.15 CASE STUDY ANALYSIS
5.15.1 MOISTURE BARRIER TECHNOLOGY FOR EFFICIENT DRUG DELIVERY
5.15.2 CUSTOM METERING VALVE FOR INHALERS
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE DRUG DELIVERY MODES
5.16.2 BUYING CRITERIA
5.16.2.1 Quality
5.16.2.2 Service
FIGURE 32 SUPPLIER SELECTION CRITERION
6 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE
6.1 INTRODUCTION
FIGURE 33 PRIMARY PACKAGING TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD
TABLE 17 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
TABLE 18 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
6.2 PRIMARY
6.2.1 INNOVATIVE PACKAGING SOLUTIONS FOR DRUG DELIVERY SYSTEMS TO DRIVE MARKET
6.3 SECONDARY
6.3.1 RISING ADOPTION OF PREFILLED CONTAINERS AND DELIVERY DEVICES TO FUEL DEMAND
7 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
7.1 INTRODUCTION
FIGURE 34 PLASTICS TO DOMINATE MARKET DURING FORECAST PERIOD
TABLE 19 BASIC PACKAGING RAW MATERIALS USED IN PHARMACEUTICAL PACKAGING
TABLE 20 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
TABLE 21 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
TABLE 22 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
TABLE 23 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
7.2 PLASTIC
7.2.1 EFFECTIVE BARRIER PROPERTIES AND COST REDUCTION TO DRIVE MARKET
TABLE 24 PLASTICS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 25 PLASTICS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
7.2.2 HIGH-DENSITY POLYETHYLENE
7.2.3 POLYESTER
7.2.4 POLYPROPYLENE
7.2.5 LOW-DENSITY POLYETHYLENE
7.2.6 POLYVINYL CHLORIDE
7.2.7 CYCLIC OLEFIN COPOLYMER
7.2.8 POLYETHYLENE TEREPHTHALATE
7.3 PAPER & PAPERBOARD
7.3.1 INNOVATIONS IN SECONDARY PACKAGING TO PROPEL MARKET
TABLE 26 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 27 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
7.4 GLASS
7.4.1 CHEMICAL RESISTANCE AND STURDINESS TO BOOST DEMAND
TABLE 28 GLASS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 29 GLASS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
TABLE 30 GLASS PACKAGING TYPES
7.5 METALS
7.5.1 INCREASING USE OF ALUMINUM FOR BLISTER PACKAGING TO DRIVE MARKET
TABLE 31 METALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 32 METALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
7.6 OTHER RAW MATERIALS
TABLE 33 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 34 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY
8.1 INTRODUCTION
FIGURE 35 ORAL DRUG DELIVERY ACCOUNTED FOR LARGEST SHARE IN 2023
TABLE 35 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 36 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
TABLE 37 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
TABLE 38 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
8.2 ORAL
8.2.1 ADOPTION OF NANOCARRIERS AND CYCLODEXTRINS TO FUEL MARKET
TABLE 39 ORAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 40 ORAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.3 PULMONARY
8.3.1 INCREASING CASES OF LUNG DISORDERS TO DRIVE MARKET
TABLE 41 PULMONARY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 42 PULMONARY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.4 TRANSDERMAL
8.4.1 SURGING DEMAND FOR PAINLESS DRUG DELIVERY AND SELF-ADMINISTRATION OF DRUGS TO FUEL MARKET
TABLE 43 TRANSDERMAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 44 TRANSDERMAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.5 INJECTABLE
8.5.1 INCREASING USE OF BIOLOGICS TO BOOST MARKET
TABLE 45 INJECTABLE: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 46 INJECTABLE: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.6 TOPICAL
8.6.1 RISING PREVALENCE OF SKIN DISEASES TO BOOST DEMAND FOR TOPICAL DRUGS
TABLE 47 TOPICAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 48 TOPICAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.7 NASAL
8.7.1 RAPID ABSORPTION AND QUICK ACTION TO FUEL DEMAND FOR NASAL DROPS
TABLE 49 NASAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 50 NASAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.8 OCULAR/OPHTHALMIC
8.8.1 INCREASING FREQUENCY OF OPTHALMIC DISEASES TO DRIVE MARKET
TABLE 51 OCULAR/OPHTHALMIC: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 52 OCULAR/OPHTHALMIC: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.9 INTRAVENOUS
8.9.1 HIGH OCCURENCE OF CHRONIC DISEASES TO FUEL MARKET
TABLE 53 INTRAVENOUS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 54 INTRAVENOUS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.10 OTHER DRUG DELIVERY MODES
TABLE 55 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 56 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
9.1 INTRODUCTION
FIGURE 36 PLASTIC BOTTLES TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
TABLE 57 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 58 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
9.2 PLASTIC BOTTLES
9.2.1 EXTENSIVE USE IN PACKAGING ORAL DRUGS TO BOOST MARKET
TABLE 59 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 60 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.2.2 STANDARD PLASTIC BOTTLES
9.2.3 PLASTIC DISPENSING BOTTLES
9.2.4 PLASTIC JARS
9.3 BLISTER PACKS
9.3.1 ANTIMICROBIAL RESISTANCE AND TAMPER-EVIDENT FEATURES TO DRIVE MARKET
TABLE 61 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 62 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.3.2 COMPARTMENT PACKS
9.3.3 WALLET PACKS
9.4 LABELS & ACCESSORIES
9.4.1 NEED FOR STRINGENT GUIDELINES ON DRUG INSTRUCTIONS TO FUEL DEMAND
TABLE 63 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 64 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.4.2 SELF ADHESIVE
9.4.3 DIE CUT
9.4.4 HOLOGRAPHIC STRIPS
9.4.5 TAMPER PROOF
9.4.6 OTHER LABELS
9.5 CAPS & CLOSURES
9.5.1 DEMAND FOR CHILD-RESISTANT AND TAMPER-EVIDENT PACKAGING TO FUEL MARKET
TABLE 65 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 66 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.6 MEDICAL SPECIALTY BAGS
9.6.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND
TABLE 67 MEDICAL SPECIALTY BAGS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 68 MEDICAL SPECIALTY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.7 PREFILLED SYRINGES
9.7.1 RISING NEED FOR HIGH-QUALITY DRUG DELIVERY SYSTEMS TO BOOST MARKET
TABLE 69 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 70 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.8 TEMPERATURE-CONTROLLED PACKAGING
9.8.1 SURGING DEMAND FOR TEMPERATURE-SENSITIVE DRUGS AND VACCINES TO FUEL MARKET
TABLE 71 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 72 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.9 POUCHES & STRIP PACKS
9.9.1 INCREASING DEMAND FOR COST-EFFECTIVE SOLUTIONS TO DRIVE MARKET
TABLE 73 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 74 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.10 AMPOULES
9.10.1 HIGH REQUIREMENT FOR SMALL DOSAGE SOLUTIONS TO DRIVE MARKET
TABLE 75 AMPOULES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 76 AMPOULES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.11 VIALS
9.11.1 CONSISTENT DEMAND FOR VIALS IN VACCINE PACKAGING TO DRIVE MARKET
TABLE 77 VIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 78 VIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.12 PREFILLED INHALERS
9.12.1 HIGH DEMAND FOR CONVENIENT AND ECO-FRIENDLY PACKAGING TO DRIVE MARKET
TABLE 79 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 80 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.12.2 METERED DOSE INHALERS
9.12.3 DRY POWDER INHALERS
9.13 MEDICATION TUBES
9.13.1 INCREASING DEMAND IN CURING SKIN AILMENTS TO DRIVE MARKET
TABLE 81 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 82 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.13.2 COMPOSITE TUBES
9.13.3 ALL-PLASTIC TUBES
9.13.4 COLLAPSIBLE METAL TUBES
9.14 JARS & CANISTERS
9.14.1 EFFECTIVE BARRIER PROPERTIES TO FUEL DEMAND FOR DESICCANT CANISTERS
TABLE 83 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 84 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.15 CARTRIDGES
9.15.1 INCREASED USE IN CHRONIC DISEASES TO DRIVE MARKET
TABLE 85 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 86 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.16 OTHER TYPES
TABLE 87 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 88 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
10 PHARMACEUTICAL PACKAGING MARKET, BY REGION
10.1 INTRODUCTION
FIGURE 37 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
TABLE 89 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
TABLE 90 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
10.2 NORTH AMERICA
10.2.1 RECESSION IMPACT
FIGURE 38 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
TABLE 91 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
TABLE 92 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 93 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 94 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
TABLE 95 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
TABLE 96 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
TABLE 97 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
TABLE 98 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
TABLE 99 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
TABLE 100 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
TABLE 101 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
TABLE 102 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
10.2.2 US
10.2.2.1 Rapid technological advancements in pharmaceutical packaging to drive market
TABLE 103 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 104 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Competitive business environment to boost market
TABLE 105 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 106 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.2.4 MEXICO
10.2.4.1 Government initiatives in healthcare industry to fuel demand for pharmaceutical products
TABLE 107 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 108 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3 EUROPE
10.3.1 RECESSION IMPACT
FIGURE 39 EUROPE: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
TABLE 109 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
TABLE 110 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 111 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 112 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
TABLE 113 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
TABLE 114 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
TABLE 115 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
TABLE 116 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
TABLE 117 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
TABLE 118 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
TABLE 119 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
TABLE 120 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
10.3.2 GERMANY
10.3.2.1 Increase in aging population and noncommunicable diseases to drive market
TABLE 121 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 122 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 High demand for generic drugs to drive market
TABLE 123 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 124 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Rising exports of pharmaceutical products to boost market
TABLE 125 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 126 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.5 UK
10.3.5.1 Innovations in drug manufacturing to drive market
TABLE 127 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 128 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Government initiatives in healthcare sector to boost demand
TABLE 129 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 130 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.7 RUSSIA
10.3.7.1 Government initiatives for domestic production of pharmaceuticals to fuel market
TABLE 131 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 132 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.8 REST OF EUROPE
TABLE 133 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 134 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4 ASIA PACIFIC
10.4.1 RECESSION IMPACT
FIGURE 40 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
TABLE 135 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
TABLE 136 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 137 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 138 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
TABLE 139 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
TABLE 140 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
TABLE 141 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
TABLE 142 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
TABLE 143 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
TABLE 144 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
TABLE 145 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
TABLE 146 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
10.4.2 CHINA
10.4.2.1 Increased investments in biologics and biosimilar drug research to drive market
TABLE 147 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 148 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4.3 JAPAN
10.4.3.1 Rise in aging population to drive demand for medications
TABLE 149 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 150 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4.4 SOUTH KOREA
10.4.4.1 Well-developed healthcare industry and presence of major pharmaceuticals manufacturers to drive market
TABLE 151 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 152 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4.5 INDIA
10.4.5.1 Large domestic consumption and export of generic drugs to drive market
TABLE 153 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 154 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4.6 AUSTRALIA
10.4.6.1 Wide adoption of Medicare and PBS schemes to drive market
TABLE 155 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 156 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4.7 REST OF ASIA PACIFIC
TABLE 157 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 158 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.5 SOUTH AMERICA
10.5.1 RECESSION IMPACT
TABLE 159 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
TABLE 160 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 161 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 162 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
TABLE 163 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
TABLE 164 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
TABLE 165 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
TABLE 166 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
TABLE 167 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
TABLE 168 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
TABLE 169 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
TABLE 170 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
10.5.2 BRAZIL
10.5.2.1 Free and universal healthcare services to boost market
TABLE 171 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 172 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.5.3 ARGENTINA
10.5.3.1 Rapid urbanization and increase in import of drugs to fuel market
TABLE 173 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 174 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.5.4 REST OF SOUTH AMERICA
TABLE 175 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 176 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 RECESSION IMPACT
TABLE 177 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
TABLE 178 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
TABLE 181 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
TABLE 182 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
TABLE 183 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
TABLE 184 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
TABLE 185 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
TABLE 186 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
TABLE 187 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
TABLE 188 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
10.6.2 GCC
10.6.2.1 UAE
10.6.2.1.1 Increasing initiatives for domestic pharmaceutical production to drive market
TABLE 189 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 190 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.6.2.2 Saudi Arabia
10.6.2.2.1 More comprehensive access to healthcare services to fuel demand for pharmaceuticals
TABLE 191 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 192 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.6.2.3 Rest of GCC
10.6.3 SOUTH AFRICA
10.6.3.1 Gradual rise in use of generic drugs to drive market
TABLE 193 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 194 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.6.4 REST OF MIDDLE EAST & AFRICA
TABLE 195 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
TABLE 196 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
FIGURE 41 OVERVIEW OF KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS BETWEEN 2019 AND 2023
11.3 REVENUE ANALYSIS
FIGURE 42 REVENUE ANALYSIS OF KEY COMPANIES (2020–2022)
11.4 MARKET SHARE ANALYSIS
11.4.1 RANKING ANALYSIS OF KEY MARKET PLAYERS, 2022
FIGURE 43 RANKING OF TOP 5 PLAYERS IN PHARMACEUTICAL PACKAGING MARKET, 2022
11.4.2 MARKET SHARE OF KEY PLAYERS, 2022
FIGURE 44 PHARMACEUTICAL PACKAGING MARKET SHARE, BY COMPANY (2022)
TABLE 197 PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 45 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX, 2022
11.5.5 COMPANY FOOTPRINT
TABLE 198 PACKAGING TYPE FOOTPRINT (25 COMPANIES)
TABLE 199 DRUG DELIVERY MODE FOOTPRINT (25 COMPANIES)
TABLE 200 REGION FOOTPRINT (25 COMPANIES)
TABLE 201 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
11.6 START-UP/SME EVALUATION MATRIX
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
FIGURE 46 PHARMACEUTICAL PACKAGING MARKET: START-UP/SME EVALUATION MATRIX, 2022
11.6.5 COMPETITIVE BENCHMARKING
TABLE 202 PHARMACEUTICAL PACKAGING MARKET: LIST OF COMPANIES (25 COMPANIES)
11.7 COMPETITIVE SCENARIO AND TRENDS
11.7.1 PRODUCT LAUNCHES/DEVELOPMENTS
TABLE 203 PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES/ DEVELOPMENTS, 2019–2023
11.7.2 DEALS
TABLE 204 PHARMACEUTICAL PACKAGING MARKET: DEALS, 2019–2023
11.7.3 OTHER DEVELOPMENTS
TABLE 205 PHARMACEUTICAL PACKAGING MARKET: OTHER DEVELOPMENTS,
2019–2023
12 COMPANY PROFILES
(Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats) *
12.1 KEY PLAYERS
12.1.1 BERRY GLOBAL INC.
TABLE 206 BERRY GLOBAL INC.: COMPANY OVERVIEW
FIGURE 47 BERRY GLOBAL INC.: COMPANY SNAPSHOT
TABLE 207 BERRY GLOBAL INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 208 BERRY GLOBAL INC.: PRODUCT LAUNCHES
TABLE 209 BERRY GLOBAL INC.: DEALS
TABLE 210 BERRY GLOBAL INC.: OTHER DEVELOPMENTS
12.1.2 GERRESHEIMER AG
TABLE 211 GERRESHEIMER AG: COMPANY OVERVIEW
FIGURE 48 GERRESHEIMER AG: COMPANY SNAPSHOT
TABLE 212 GERRESHEIMER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 213 GERRESHEIMER AG: PRODUCT LAUNCHES
TABLE 214 GERRESHEIMER AG: DEALS
TABLE 215 GERRESHEIMER AG: OTHER DEVELOPMENTS
12.1.3 AMCOR PLC
TABLE 216 AMCOR PLC: COMPANY OVERVIEW
FIGURE 49 AMCOR PLC: COMPANY SNAPSHOT
TABLE 217 AMCOR PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 218 AMCOR PLC: PRODUCT LAUNCHES
TABLE 219 AMCOR PLC: DEALS
TABLE 220 AMCOR PLC: OTHER DEVELOPMENTS
12.1.4 SCHOTT AG
TABLE 221 SCHOTT AG: COMPANY OVERVIEW
FIGURE 50 SCHOTT AG: COMPANY SNAPSHOT
TABLE 222 SCHOTT AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 223 SCHOTT AG: PRODUCT LAUNCHES
TABLE 224 SCHOTT AG: DEALS
TABLE 225 SCHOTT AG: OTHER DEVELOPMENTS
12.1.5 APTARGROUP, INC.
TABLE 226 APTARGROUP, INC.: COMPANY OVERVIEW
FIGURE 51 APTARGROUP, INC.: COMPANY SNAPSHOT
TABLE 227 APTARGROUP, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 228 APTARGROUP, INC.: PRODUCT LAUNCHES
TABLE 229 APTARGROUP, INC.: DEALS
TABLE 230 APTARGROUP, INC.: OTHER DEVELOPMENTS
12.1.6 BD
TABLE 231 BD: COMPANY OVERVIEW
FIGURE 52 BD: COMPANY SNAPSHOT
TABLE 232 BD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 233 BD: PRODUCT LAUNCHES
TABLE 234 BD: DEALS
TABLE 235 BD: OTHER DEVELOPMENTS
12.1.7 WESTROCK COMPANY
TABLE 236 WESTROCK COMPANY: COMPANY OVERVIEW
FIGURE 53 WESTROCK COMPANY: COMPANY SNAPSHOT
TABLE 237 WESTROCK COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 238 WESTROCK COMPANY: DEALS
TABLE 239 WESTROCK COMPANY: OTHER DEVELOPMENTS
12.1.8 NIPRO CORPORATION
TABLE 240 NIPRO CORPORATION: COMPANY OVERVIEW
FIGURE 54 NIPRO CORPORATION: COMPANY SNAPSHOT
TABLE 241 NIPRO CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 242 NIPRO CORPORATION: PRODUCT LAUNCHES
TABLE 243 NIPRO CORPORATION: DEALS
12.1.9 CATALENT, INC.
TABLE 244 CATALENT, INC.: COMPANY OVERVIEW
FIGURE 55 CATALENT, INC.: COMPANY SNAPSHOT
TABLE 245 CATALENT, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 246 CATALENT, INC.: DEALS
TABLE 247 CATALENT, INC.: OTHER DEVELOPMENTS
12.1.10 SEALED AIR
TABLE 248 SEALED AIR: COMPANY OVERVIEW
FIGURE 56 SEALED AIR: COMPANY SNAPSHOT
TABLE 249 SEALED AIR: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 250 SEALED AIR: PRODUCT LAUNCHES
TABLE 251 SEALED AIR: DEALS
12.1.11 WEST PHARMACEUTICAL SERVICES, INC.
TABLE 252 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW
FIGURE 57 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT
TABLE 253 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 254 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT LAUNCHES
TABLE 255 WEST PHARMACEUTICAL SERVICES, INC.: OTHER DEVELOPMENTS
*Details on Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS
12.2.1 ALPLA
TABLE 256 ALPLA: COMPANY OVERVIEW
12.2.2 ARDAGH GROUP S.A.
TABLE 257 ARDAGH GROUP S.A.: COMPANY OVERVIEW
12.2.3 CCL INDUSTRIES INC.
TABLE 258 CCL INDUSTRIES INC.: COMPANY OVERVIEW
12.2.4 FRANK NOE
TABLE 259 FRANK NOE: COMPANY OVERVIEW
12.2.5 GAPLAST GMBH
TABLE 260 GAPLAST GMBH: COMPANY OVERVIEW
12.2.6 LONZA
TABLE 261 LONZA: COMPANY OVERVIEW
12.2.7 MONDI GROUP
TABLE 262 MONDI GROUP: COMPANY OVERVIEW
12.2.8 NOLATO AB
TABLE 263 NOLATO AB: COMPANY OVERVIEW
12.2.9 ORIGIN PHARMA PACKAGING
TABLE 264 ORIGIN PHARMA PACKAGING: COMPANY OVERVIEW
12.2.10 COMAR
TABLE 265 COMAR: COMPANY OVERVIEW
12.2.11 BILCARE LIMITED
TABLE 266 BILCARE LIMITED: COMPANY OVERVIEW
12.2.12 SGD PHARMA
TABLE 267 SGD PHARMA: COMPANY OVERVIEW
12.2.13 SILGAN HOLDINGS INC.
TABLE 268 SILGAN HOLDINGS INC.: COMPANY OVERVIEW
12.2.14 VETTER PHARMA INTERNATIONAL GMBH
TABLE 269 VETTER PHARMA INTERNATIONAL GMBH: COMPANY OVERVIEW
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
The report “Pharmaceutical Packaging Market by Packaging Type, by Raw Material, by Drug Delivery Type by Region(North America, Europe, Asia-Pacific, RoW) - Forecasts to 2020” defines and segments the pharmaceutical packaging market with an analysis and forecast of value by type.
The market for pharmaceutical packaging, in terms of value, is projected to reach more than $80 Billion by 2020, witnessing a CAGR around 6.50% between 2015 and 2020.
The report also identifies the driving and restraining factors for the pharmaceutical packaging market with an analysis of drivers, restraints, opportunities, and strengths.
The market is segmented and the value has been projected on the basis of important regions, such as Asia-Pacific, North America, Europe, and Rest of the World (RoW). Further, the market is segmented and the volume and value are estimated based on various key raw materials and drug delivery types, such as oral, pulmonary, transdermal, injectable, topical, nasal, ocular, IV drugs, and other.
In developed countries, the growth of the injectable drug delivery technologies and solutions market is fast and contributes significantly to the pharmaceutical packaging market. This market is driven by factors such as innovations in injectable drug delivery devices, rising prevalence of diabetes in the U.S., the U.K., Germany, Italy, France, and Canada, improving patient safety & compliance and rise in partnerships, and collaborations and acquisitions among prominent players in this market.
In terms of value, North America followed by Europe dominated the pharmaceutical packaging market in 2014 and are projected to register a steady CAGR till 2020. High technological innovation and high environmental awareness along with moderate growth in the pharmaceutical market in the North American and European regions is leading to high consumption of pharmaceutical packaging in these regions. Due to rising spending capacity of consumers in the region, the pharmaceutical market is projected to witness a steady growth rate in Asia-Pacific and RoW. The pharmaceutical packaging market in Asia-Pacific is expected to witness highest growth rate between 2015 and 2020.
North America is the largest market for pharmaceutical packaging currently; however, by 2020, Asia-Pacific is expected to be the largest market. This growth is expected to be highest in the emerging economies of Brazil, Russia, India, and China, especially due to higher generics and contract manufacturing activities in these countries. Huge population and favorable demographics of these countries are key drivers behind this growth.
